SCHEMBL6874159

SCHEMBL6874159

CPNCCCc1cc(C#N)ccc1OCCO

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 1/20 0.38
PPARA Q07869 1/20 0.38
MTNR1B P49286 5/20 0.36
MTNR1A P48039 4/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
CYP19A1 P11511 2/20 0.34
CYP11B1 P15538 2/20 0.34
CYP11B2 P19099 2/20 0.34
SLC6A4 P31645 3/20 0.34
KCNH2 Q12809 2/20 0.34
SLC6A3 Q01959 1/20 0.34
HTR2A P28223 1/20 0.33
GAA P10253 1/20 0.33
LTB4R Q15722 1/20 0.32
PDE5A O76074 2/20 0.32
PDCD1 Q15116 1/20 0.32
CD274 Q9NZQ7 1/20 0.32
CNR1 P21554 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6873571 0.91 CYP19A1 (0.37) PTGDR2CYP19A1CYP11B1CYP11B2KCNH2
SCHEMBL13552197 0.82 PPARD (0.45) PPARDPPARAMTNR1BMTNR1APTGDR2
SCHEMBL9883004 0.79 PPARD (0.47) PPARDPPARAMTNR1BMTNR1APTGDR2
SCHEMBL6876936 0.79 PRSS1 (0.47)
SCHEMBL6875629 0.78 HRH1 (0.41) PPARD
SCHEMBL10051307 0.74 SLC6A4 (0.39) CYP11B1CYP11B2SLC6A4KCNH2LTB4R
SCHEMBL6877955 0.74 AR (0.37) CNR1
SCHEMBL14046843 0.72 BUB1 (0.37) CNR1
SCHEMBL6872377 0.71 PRSS1 (0.47)
SCHEMBL29577607 0.71 PTGDR2 (0.48) PPARDPPARAPTGDR2CYP19A1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011050270-A2 MACROCYCLIC INHIBITORS OF SERINE PROTEASE ENZYMES TRANZYME PHARMA, INC. (US) 2011-04-28 WO disclosed
WO-2011050276-A1 METHODS OF USING MACROCYCLIC INHIBITORS OF SERINE PROTEASE ENZYMES TRANZYME PHARMA, INC. (US) 2011-04-28 WO disclosed